Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Monoclonal Antibody
100%
P450
100%
CYP2C19
100%
Human Cytochrome P450
100%
Cytochrome P450 2C8
100%
Cytochrome P450 2C9 (CYP2C9)
100%
P450s
28%
Large Potential
14%
Metabolism
14%
Polymorphism
14%
Metabolic
14%
Inhibitory Activity
14%
Inter-individual Variation
14%
Drug Discovery
14%
Drug Interactions
14%
Immunoblot
14%
Analytics Systems
14%
Cytochrome P450 (CYP450)
14%
Adverse Drug Reaction
14%
Xenobiotics
14%
Diclofenac
14%
Hybridoma
14%
Cytochrome P450 Isoforms
14%
Diazepam
14%
Imipramine
14%
Tolbutamide
14%
Mephenytoin
14%
Human Liver Microsomes
14%
Non-drug
14%
P450 2C19
14%
P450 2C9
14%
Drug Pathway
14%
Taxol/paclitaxel
14%
Combinatorial Use
14%
In Vivo Phenotyping
14%
Neuroscience
Monoclonal Antibody
100%
Cytochrome P450 2C9
100%
Cytochrome P450
100%
Cytochrome P450 2C19
100%
Cytochrome P450 2C8
100%
Paclitaxel
18%
In Vivo
9%
Tolbutamide
9%
Imipramine
9%
Microsome
9%
Metabolic Pathway
9%
Immunoblotting
9%
Diazepam
9%
Diclofenac
9%
Drug Interaction
9%
Mephenytoin
9%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2C9
100%
CYP2C8
100%
Cytochrome P450
100%
CYP2C19
100%
Monoclonal Antibody
100%
Paclitaxel
18%
Drug Discovery
9%
Western Blot
9%
Adverse Drug Reaction
9%
Diazepam
9%
Mephenytoin
9%
Diclofenac
9%
Tolbutamide
9%
Imipramine
9%
Drug Interaction
9%
Immunology and Microbiology
Monoclonal Antibody
100%
Cytochrome P450
100%
Western Blot
20%
Xenobiotic
20%
Drug Hypersensitivity
20%
Liver Microsome
20%
Drug Interaction
20%
Hybridoma
20%